Phase Iib
Entity.
- Evidence
- 28 documents · 10 separate publishers
- Standing
- A name from our starting list; its record is kept up to date automatically from coverage
- Time
- first seen 21 Sept 2026, last seen 13 Oct 2026
- Measured
- 18% of mentions say something specific about it; the rest only name it
- As of
- 15 Oct 2026
Where this comes from
- Clinical Trials Arena · 2026-10-13 · Tortugas’ Phase IIb schizophrenia trial of obuprazine meets primary endpoint (opens the source in a new tab)
- Clinical Trials Arena · 2026-10-09 · Endeavor’s Phase IIb IPF study of taladegib meets endpoints (opens the source in a new tab)
- Clinical Trials Arena · 2026-10-08 · MimiVax announces disappointing pivotal Phase IIb trial data for cancer vaccine (opens the source in a new tab)
- AllSci News · 2026-10-07 · SurVaxM misses Phase IIb glioblastoma survival endpoint but shows benefit in younger patients (opens the source in a new tab)
- Clinical Trials Arena · 2026-10-01 · R1 Therapeutics secures $80.5m to fund Phase IIb AP306 study (opens the source in a new tab)
- AllSci News · 2026-10-01 · R1 Therapeutics expands Series A to USD 80.5m as AP306 nears Phase IIb readout (opens the source in a new tab)
- Clinical Trials Arena · 2026-10-01 · MSD’s Phase IIb study of tulisokibart achieves primary endpoint (opens the source in a new tab)
- AllSci News · 2026-10-01 · Lilly's EloraTZP combination tops tirzepatide alone in Phase IIb obesity and diabetes trial (opens the source in a new tab)
- Clinical Trials Arena · 2026-09-23 · Vertex reports results from Phase IIb AMPLIFIED trial for AMKD (opens the source in a new tab)
- Clinical Trials Arena · 2026-09-21 · First patient dosed in Accro Bioscience’s Phase IIb AC-101 study (opens the source in a new tab)
- The Clinical Trial Vanguard · 2026-09-21 · Accro Bioscience Doses First Patient in AC-101 Phase IIb Trial for Ulcerative Colitis (opens the source in a new tab)